REFERENCES
- Deferm S, Bertrand PB, Verbrugge FH, et al. Atrial functional mitral
regurgitation: JACC review topic of the week. J Am Coll Cardiol.
2019;73(19):2465-2476.
- Chehab O, Roberts-Thomson R, Ng YLC, et al. Secondary mitral
regurgitation: pathophysiology, proportionality and prognosis. Heart.
2020;106(10):716-723.
- Asgar AW, Mack MJ, Stone GW. Secondary mitral regurgitation in heart
failure: pathophysiology, prognosis, and therapeutic considerations. J
Am Coll Cardiol. 2015;65(12):1231-1248.
- Iung B, Vahanian A. Epidemiology of valvular heart disease in the
adult. Nat Rev Cardiol. 2011;8(3):162-172.
- Bartko PE, Hülsmann M, Hung J, et al. Secondary valve regurgitation in
patients with heart failure with preserved ejection fraction, heart
failure with mid-range ejection fraction, and heart failure with
reduced ejection fraction [published online ahead of print, 2020 Apr
29]. Eur Heart J. 2020;ehaa129.
- Dziadzko V, Clavel MA, Dziadzko M, et al. Outcome and undertreatment
of mitral regurgitation: a community cohort study. Lancet.
2018;391(10124):960-969.
- Baumgartner H, Falk V, Bax JJ, et al. 2017 ESC/EACTS Guidelines for
the management of valvular heart disease. Eur Heart J.
2017;38(36):2739-2791
- Nishimura RA, Otto CM, Bonow RO, et al. 2017 AHA/ACC focused update of
the 2014 AHA/ACC guideline for the management of patients with
valvular heart disease: a report of the American College of
Cardiology/American Heart Association Task Force on clinical practice
guidelines. J Am Coll Cardiol. 2017;70(2):252-289.
- Bonow RO, O’Gara PT, Adams DH, et al. 2020 Focused Update of the 2017
ACC Expert Consensus Decision Pathway on the management of mitral
regurgitation: a report of the American College of Cardiology Solution
Set Oversight Committee. J Am Coll Cardiol. 2020;75(17):2236-2270
- Goel SS, Bajaj N, Aggarwal B, et al. Prevalence and outcomes of
unoperated patients with severe symptomatic mitral regurgitation and
heart failure: comprehensive analysis to determine the potential role
of MitraClip for this unmet need. J Am Coll Cardiol.
2014;63(2):185-186.
- Acker MA, Parides MK, Perrault LP, et al. Mitral-valve repair versus
replacement for severe ischemic mitral regurgitation. N Engl J Med.
2014;370(1):23-32.
- Goldstein D, Moskowitz AJ, Gelijns AC, et al. Two-year outcomes of
surgical treatment of severe ischemic mitral regurgitation. N Engl J
Med. 2016;374(4):344-353.
- Smith PK, Puskas JD, Ascheim DD, et al. Surgical treatment of moderate
ischemic mitral regurgitation. N Engl J Med. 2014;371(23):2178-2188.
- Michler RE, Smith PK, Parides MK, et al. Two-year outcomes of surgical
treatment of moderate ischemic mitral regurgitation. N Engl J Med.
2016;374(20):1932-1941.
- Obadia JF, Messika-Zeitoun D, Leurent G, et al. Percutaneous repair or
medical treatment for secondary mitral regurgitation. N Engl J Med.
2018;379(24):2297-2306.
- Stone GW, Lindenfeld J, Abraham WT, et al. Transcatheter mitral-valve
repair in patients with heart failure. N Engl J Med.
2018;379(24):2307-2318.
- Wan S, Hu J. Commentary: Following the game-changers: Are we on the
right track now? J Thorac Cardiovasc Surg. (in press)
Doi:10.1016/j.jtcvs.2020.06.070
- Sannino A, Smith RL 2nd, Schiattarella GG, et al. Survival and
cardiovascular outcomes of patients with secondary mitral
regurgitation: a systematic review and meta-analysis. JAMA Cardiol.
2017;2(10):1130-1139.
- Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the
diagnosis and treatment of acute and chronic heart failure: The Task
Force for the diagnosis and treatment of acute and chronic heart
failure of the European Society of Cardiology (ESC)Developed with the
special contribution of the Heart Failure Association (HFA) of the
ESC. Eur Heart J. 2016;37(27):2129-2200.
- Nieminen MS, Brutsaert D, Dickstein K, et al. EuroHeart Failure Survey
II (EHFS II): a survey on hospitalized acute heart failure patients:
description of population. Eur Heart J. 2006;27(22):2725-36.
- Díez-Villanueva P, Vera A, Ariza-Solé A, et al. Mitral regurgitation
and prognosis after non-ST-segment elevation myocardial infarction in
very old patients. J Am Geriatr Soc. 2019;67(8):1641-1648.
- Barra S, Providência R, Paiva L, et al. Mitral regurgitation during a
myocardial infarction–new predictors and prognostic significance at
two years of follow-up. Acute Card Care. 2012;14(1):27-33.
- Valuckienė Ž, Urbonaitė D, Jurkevičius R. Functional (ischemic) mitral
regurgitation in acute phase of myocardial infarction: Associated
clinical factors and in-hospital outcomes. Medicina (Kaunas).
2015;51(2):92-9.
- The Writing Committee of the Report on Cardiovascular Health and
Diseases in China. Report on cardiovascular health and diseases in
China 2019: an updated summary. Chinese Circulation Journal,
2020;35:833.
- Zhang Y, Zhang J, Butler J, et al. Contemporary epidemiology,
management, and outcomes of patients hospitalized for heart failure in
China: results from the China Heart Failure (China-HF) Registry. J
Card Fail. 2017;23(12):868-875.
- Guan W, Venkatesh AK, Bai X, et al. Time to hospital arrival among
patients with acute myocardial infarction in China: a report from
China PEACE prospective study. Eur Heart J Qual Care Clin Outcomes.
2019;5(1):63-71.
- Hao G, Wang X, Chen Z, et al. Prevalence of heart failure and left
ventricular dysfunction in China: the China Hypertension Survey,
2012-2015. Eur J Heart Fail. 2019;21(11):1329-1337.
- Mentias A, Raza MQ, Barakat AF, et al. Prognostic significance of
ischemic mitral regurgitation on outcomes in acute ST-elevation
myocardial infarction managed by primary percutaneous coronary
intervention. Am J Cardiol. 2017;119(1):20-26.
- Kaneko H, Suzuki S, Uejima T, et al. Prevalence and the long-term
prognosis of functional mitral regurgitation in Japanese patients with
symptomatic heart failure. Heart Vessels. 2014;29(6):801-7.
- Naser N, Dzubur A, Kusljugic Z, et al. Echocardiographic assessment of
ischaemic mitral regurgitation, mechanism, severity, impact on
treatment strategy and long term outcome. Acta Inform Med.
2016;24(3):172-7.
- Li L, Liu R, Jiang C, et al. Assessing the evidence-practice gap for
heart failure in China: the Heart Failure Registry of Patient Outcomes
(HERO) study design and baseline characteristics. Eur J Heart Fail.
2020 Apr;22(4):646-660.
- Oliva F, Mortara A, Cacciatore G, et al. Acute heart failure patient
profiles, management and in-hospital outcome: results of the Italian
Registry on Heart Failure Outcome. Eur J Heart Fail.
2012;14(11):1208-17.
- Kajimoto K, Minami Y, Otsubo S, et al. Ischemic or nonischemic
functional mitral regurgitation and outcomes in patients with acute
decompensated heart failure with preserved or reduced ejection
fraction. Am J Cardiol. 2017;120(5):809-816.
- Perez de Isla L, Zamorano J, Quezada M, et al. Prognostic significance
of functional mitral regurgitation after a first non-ST-segment
elevation acute coronary syndrome. Eur Heart J. 2006;27(22):2655-60.
- Li J, Li X, Wang Q, et al. ST-segment elevation myocardial infarction
in China from 2001 to 2011 (the China PEACE-Retrospective Acute
Myocardial Infarction Study): a retrospective analysis of hospital
data. Lancet. 2015;385(9966):441-51.
- Hillis GS, Møller JE, Pellikka PA, et al. Prognostic significance of
echocardiographically defined mitral regurgitation early after acute
myocardial infarction. Am Heart J. 2005;150(6):1268-75.
- Grayburn PA, Sannino A, Packer M. Proportionate and disproportionate
functional mitral regurgitation: a new conceptual framework that
reconciles the results of the MITRA-FR and COAPT trials. JACC
Cardiovasc Imaging. 2019;12(2):353-362.
- Milton Packer, Paul A Grayburn. Contrasting effects of
pharmacological, procedural, and surgical interventions on
proportionate and disproportionate functional mitral regurgitation in
chronic heart failure. Circulation. 2019;140(9):779-789.
- Milton Packer, Paul A Grayburn. New evidence supporting a novel
conceptual framework for distinguishing proportionate and
disproportionate functional mitral regurgitation. JAMA Cardiol. 2020;
5(4):469-475.
- Kampaktsis PN, Lebehn M, Wu IY. Mitral regurgitation in 2020: the 2020
focused update of the 2017 American College of Cardiology Expert
Consensus Decision Pathway on the management of mitral regurgitation.
J Cardiothorac Vasc Anesth. 2020:S1053-0770(20)30851-X.
- Fanaroff AC, Califf RM, Harrington RA, et al. Randomized trials versus
common sense and clinical observation: JACC review topic of the week.
J Am Coll Cardiol. 2020;76(5):580-589.
- Biner S, Rafique A, Rafii F, et al. Reproducibility of proximal
isovelocity surface area, vena contracta, and regurgitant jet area for
assessment of mitral regurgitation severity. JACC Cardiovasc Imaging.
2010;3(3):235-43.
- Shanks M, Siebelink HM, Delgado V, et al. Quantitative assessment of
mitral regurgitation: comparison between three-dimensional
transesophageal echocardiography and magnetic resonance imaging. Circ
Cardiovasc Imaging. 2010;3(6):694-700.
- Feldman T, Foster E, Glower DD, et al. Percutaneous repair or surgery
for mitral regurgitation [published correction appears in N Engl J
Med. 2011 Jul 14;365(2):189. Glower, Donald G [corrected to Glower,
Donald D]]. N Engl J Med. 2011;364(15):1395-1406.
- Gammie JS, Chikwe J, Badhwar V, et al. Isolated mitral valve surgery:
the Society of Thoracic Surgeons Adult Cardiac Surgery Database
analysis. Ann Thorac Surg. 2018;106(3):716-727.
- Nappi F, Antoniou GA, Nenna A, et al. Treatment options for ischemic
mitral regurgitation: A meta-analysis. J Thorac Cardiovasc Surg.
2020:S0022-5223(20)31262-9.
- Monteagudo Ruiz JM, Zamorano Gómez JL. Importance of the left
ventricle in secondary mitral regurgitation. Hunt with cats and you
catch only rats. Rev Esp Cardiol (Engl Ed). 2019;72(12):994-997.
- Nappi F, Avtaar Singh SS, Padala M, et al. The choice of treatment in
ischemic mitral regurgitation with reduced left ventricular function.
Ann Thorac Surg. 2019;108(6):1901-1912.
- Calafiore AM, Prapas S, Abukoudair W, et al. Has moderate ischemic
mitral regurgitation to be corrected?-Analysis of a randomized trial.
Ann Transl Med. 2016;4(Suppl 1):S66.
- Taramasso M, Maisano F. Valvular disease: Functional mitral
regurgitation: should all valves be replaced? Nat Rev Cardiol.
2016;13(2):65-6.
- Capoulade R, Zeng X, Overbey JR, et al. Impact of left ventricular to
mitral valve ring mismatch on recurrent ischemic mitral regurgitation
after ring annuloplasty. Circulation. 2016;134(17):1247-1256.
- Kron IL, Hung J, Overbey JR, et al. Predicting recurrent mitral
regurgitation after mitral valve repair for severe ischemic mitral
regurgitation. J Thorac Cardiovasc Surg. 2015;149(3):752-61.e1.
- Mihos CG, Capoulade R, Yucel E, et al. Mitral valve and subvalvular
repair for secondary mitral regurgitation: rationale and clinical
outcomes of the papillary muscle sling. Cardiol Rev. 2018;26(1):22-28.
- Wan S, Hu J, Liu J. Reply: Anatomical or functional repair for
ischemic mitral regurgitation: Find the right antidote! J Thorac
Cardiovasc Surg (in press) Doi:10.1016/j.jtcvs.2021.01.073
- Nappi F, Spadaccio C, Nenna A, et al. Is subvalvular repair worthwhile
in severe ischemic mitral regurgitation? Subanalysis of the Papillary
Muscle Approximation trial. J Thorac Cardiovasc Surg.
2017;153(2):286-295.e2.
- Szymanski C, Bel A, Cohen I, et al. Comprehensive annular and
subvalvular repair of chronic ischemic mitral regurgitation improves
long-term results with the least ventricular remodeling. Circulation.
2012;126(23):2720-7.
- Maisano F, Franzen O, Baldus S, et al. Percutaneous mitral valve
interventions in the real world: early and 1-year results from the
ACCESS-EU, a prospective, multicenter, nonrandomized post-approval
study of the MitraClip therapy in Europe. J Am Coll Cardiol.
2013;62(12):1052-1061.
- Fan Y, Wan S, Wong RH, Lee AP. Atrial functional mitral regurgitation:
mechanisms and surgical implications. Asian Cardiovasc Thorac Annals.
2020;28:421–426.